Howard Thom

23PUBLICATIONS

80CO-AUTHORS

Regenerative medicine (incl. stem cells)Predictive and prognostic markersMolecular targetsMedical virologyClinical microbiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Aug 11, 2026

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.

|Feb 02, 2026

Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makers.

A E Ades, Annabel L Davies, David M Phillippo

|Jan 06, 2026

Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer.

Neal Shore, Alicia K Morgans, Noman Paracha

|Nov 06, 2025

External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness.

Christopher G Fawsitt, Howard Thom, David Aceituno

|Dec 07, 2024

Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.

Eve Tomlinson, Mary Ward, Chris Cooper

|Sep 17, 2024

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data.

Simon Shohet, Noemi Hummel, Shuai Fu

Pageof 4

Frequent Collaborators

Penny Whiting

Edna Keeney

Nicky J Welton

Hayley E Jones

Jessica Watson

Peter Nash

Matthias Hunger

Chrysostomos Kalyvas

Kunal K Gandhi

Steffen M Jugl

Frequent Collaborators

Penny Whiting

Edna Keeney

Nicky J Welton

Hayley E Jones